Stockscreener 앱 받기
5.2312
2.74%
0.1312
전일 마감가:
$5.10
열려 있는:
$5.18
하루 거래량:
2.12M
Relative Volume:
0.36
시가총액:
$929.07M
수익:
$2.54B
순이익/손실:
$-207.36M
주가수익비율:
-4.396
EPS:
-1.19
순현금흐름:
$151.25M
1주 성능:
+12.68%
1개월 성능:
+6.71%
6개월 성능:
-31.33%
1년 성능:
-43.05%
1일 변동 폭
$5.1226
$5.325
1주일 범위
$4.76
$5.4885
52주 변동 폭
$4.40
$9.905
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
5.235 | 905.11M | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
185.58 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
52.00 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.66 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.24 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.57 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-07-25 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Buy |
| 2024-09-17 | 재확인 | Jefferies | Hold |
| 2024-02-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
| 2022-08-12 | 개시 | DA Davidson | Buy |
| 2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
| 2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
| 2022-07-06 | 재확인 | BofA Securities | Neutral |
| 2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
| 2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-03 | 업그레이드 | Argus | Hold → Buy |
| 2022-02-23 | 재확인 | BofA Securities | Neutral |
| 2022-02-23 | 재확인 | Craig Hallum | Hold |
| 2022-02-23 | 재확인 | Evercore ISI | In-line |
| 2022-02-23 | 재확인 | Goldman | Buy |
| 2022-02-23 | 재확인 | JP Morgan | Overweight |
| 2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 재확인 | Needham | Buy |
| 2022-02-23 | 재확인 | Oppenheimer | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-08 | 재확인 | Piper Sandler | Overweight |
| 2021-12-02 | 재개 | Jefferies | Hold |
| 2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-28 | 재확인 | Barclays | Equal Weight |
| 2021-10-28 | 재확인 | BofA Securities | Neutral |
| 2021-10-28 | 재확인 | Canaccord Genuity | Buy |
| 2021-10-28 | 재확인 | Citigroup | Buy |
| 2021-10-28 | 재확인 | Craig Hallum | Hold |
| 2021-10-28 | 재확인 | Needham | Buy |
| 2021-10-28 | 재확인 | Oppenheimer | Outperform |
| 2021-10-28 | 재확인 | Piper Sandler | Overweight |
| 2021-10-28 | 재확인 | UBS | Neutral |
| 2021-10-19 | 개시 | Wells Fargo | Overweight |
| 2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
| 2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-15 | 개시 | Needham | Buy |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-12-22 | 개시 | Evercore ISI | In-line |
| 2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 개시 | Goldman | Neutral |
| 2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 개시 | DA Davidson | Buy |
| 2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-07-13 | 개시 | Argus | Buy |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 개시 | UBS | Neutral |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
How Do Investors Really Feel About Teladoc Health Inc? - Benzinga
Teladoc Health CLO sold $138,583 in TDOC stock - Investing.com
[Form 4] Teladoc Health, Inc. Insider Trading Activity - Stock Titan
Teladoc Health (NYSE: TDOC) CEO reports stock sale and major equity grants - Stock Titan
Teladoc (TDOC) CAO sells shares, receives RSU and PSU grants - Stock Titan
Teladoc (NYSE: TDOC) executive sells shares and receives large equity awards - Stock Titan
Teladoc Health to Participate in Upcoming Investor Conference - Barchart.com
Teladoc Health (NYSE:TDOC) Russell 1000 Drops on Target Cut - Kalkine Media
Teladoc Health (TDOC): Oppenheimer Adjusts Price Target Amidst C - GuruFocus
Teladoc Health (TDOC) Analyst Rating: Citigroup Lowers Price Tar - GuruFocus
Fernando Rodrigues (TDOC) files to sell 25,086 vested shares on NYSE - Stock Titan
Oppenheimer Cuts Teladoc Health (NYSE:TDOC) Price Target to $7.00 - MarketBeat
Oppenheimer Adjusts Price Target on Teladoc Health to $7 From $12, Maintains Outperform Rating - marketscreener.com
Vanguard Group Inc. Raises Stock Holdings in Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Teladoc (NYSE: TDOC) executive sale covers taxes and adds 173,010 RSUs - Stock Titan
Teladoc Health, Inc. expands virtual care to meet broad employee needs for VSP Vision - Traders Union
[144] Teladoc Health, Inc. SEC Filing - Stock Titan
26,647-share Form 144 notice for TDOC (NYSE: TDOC) by Fidelity - Stock Titan
27,083-Share Vesting Sale Filed by TDOC (NYSE: TDOC) - Stock Titan
Carlos Nueno Plana to sell 20,165 TDOC shares via Fidelity (TDOC) - Stock Titan
Teladoc Health Q4 Earnings Call Highlights - Yahoo Finance
A Look At Teladoc Health’s Valuation As 2025 Results And 2026 Outlook Refocus Attention On The Stock - Sahm
UBS Adjusts Price Target on Teladoc Health to $6 From $9, Maintains Neutral Rating - marketscreener.com
TDOC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Insider sale notice: TDOC (NYSE: TDOC) 50,145 restricted shares - Stock Titan
Teladoc Health Q4 2025 Earnings: Revenue Beat, Weak 2026 GuidanceNews and Statistics - IndexBox
Canaccord Genuity Group Has Lowered Expectations for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
Teladoc Health (TDOC) Analyst Rating Maintained, Price Target Lo - GuruFocus
Teladoc projects lower integrated care membership amid ACA subsidy lapse - Healthcare Dive
Teladoc Health (TDOC) Surges 14% After Beating Q4 2025 Estimates - GuruFocus
Demystifying Teladoc Health: Insights From 8 Analyst Reviews - Benzinga
TDOC: BMO Capital Lowers Price Target, Maintains Market Perform Rating | TDOC Stock News - GuruFocus
Teladoc Health (NYSE:TDOC) Given New $6.00 Price Target at TD Cowen - MarketBeat
BMO Capital Markets Issues Pessimistic Forecast for Teladoc Health (NYSE:TDOC) Stock Price - MarketBeat
These Analysts Slash Their Forecasts On Teladoc Health After Q4 Results - Benzinga
Why Teladoc (TDOC) Stock Is Up Today - Yahoo Finance
BofA upgrades Teladoc stock rating on BetterHelp margin outlook By Investing.com - Investing.com Canada
Teladoc Health (NYSE:TDOC) Stock Rating Upgraded by Bank of America - MarketBeat
TDOC's Price Target Lowered by Piper Sandler Amid Overweight Rat - GuruFocus
Teladoc upgraded at BofA on BetterHelp prospects (TDOC:NYSE) - Seeking Alpha
Teladoc Tops Q4 Earnings Estimates on International Growth & Lower Costs - Yahoo Finance
Evercore ISI Group Maintains In-Line Rating for TDOC, Lowers Pri - GuruFocus
Wells Fargo Adjusts Price Target for TDOC, Maintains Equal-Weigh - GuruFocus
Teladoc Health (NYSE:TDOC) Earns Overweight Rating from Piper Sandler - MarketBeat
Teladoc Health Inc. Beats Expectations and Names New Board Members - StocksToTrade
Teladoc Health (TDOC): Analyst Maintains 'Hold' Rating, Lowers P - GuruFocus
Teladoc Health (NYSE:TDOC) Price Target Cut to $6.00 by Analysts at Wells Fargo & Company - MarketBeat
Stifel cuts Teladoc stock price target to $6 on revenue pressures - Investing.com Canada
Teladoc Health, Inc. SEC 10-K Report - TradingView
Teladoc Health (NYSE:TDOC) Shares Up 14.6% on Earnings Beat - MarketBeat
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.82%
0.50%
자본화:
|
볼륨(24시간):